Heterobiarly derivatives and pharmaceutical compositions thereof
US5418233A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Oct 14, 1992 |
| Grant date | May 23, 1995 |
| Priority date | — |
| Expiry date | Oct 14, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/650905
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Heterobiaryl derivatives of the formula EQU R.sub.1 NH--X.sub.1 --X.sub.2 --X.sub.3 --Y.sub.1 --Y.sub.2 --Y.sub.3 --Y.sub.4 --E (I) wherein PA0 R.sub.1, X.sub.1 to X.sub.3 and Y.sub.1 to Y.sub.4 are as defined herein, the tautomers, stereoisomers and mixtures thereof, and the salts, particularly the physiologically acceptable salts, thereof with organic or inorganic acids or bases. The derivatives have valuable pharmacological properties, such as inhibiting cell-cell aggregation and cell-matrix interactions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.